Related Experiment Videos
Receptor-effector coupling dysfunctions in Alzheimer's disease
C J Fowler1, A Garlind, C O'Neill
1Department of Pharmacology Umeå University, Sweden.
Annals of the New York Academy of Sciences
|June 15, 1996
Summary
Alzheimer's disease (AD) brains show defective neurotransmitter systems, including G protein and protein kinase C, and reduced Ins(1,4,5)P3 receptors. These signal transduction issues may hinder neurotransmitter replacement therapies.
Area of Science:
- Neuroscience
- Biochemistry
Background:
- Alzheimer's disease (AD) is characterized by progressive neurodegeneration.
- Neurotransmitter systems play a crucial role in brain function.
Purpose of the Study:
- To investigate signal transduction pathway defects in the AD brain.
- To determine the impact of these defects on potential therapeutic strategies.
Main Methods:
- Analysis of G protein function.
- Assessment of protein kinase C activity.
- Quantification of inositol 1,4,5-trisphosphate (Ins(1,4,5)P3) receptors.
Main Results:
- Defective G protein and protein kinase C function observed in AD brains.
- Significantly reduced levels of Ins(1,4,5)P3 receptors found.
- Abnormalities detected even in brain regions with minimal histopathological changes, such as the cerebellum.
Conclusions:
- Signal transduction pathway defects are prevalent in the AD brain.
- These abnormalities may occur early in the disease process.
- Such defects could limit the efficacy of neurotransmitter replacement therapies for AD.